Evaluate the Benefit of RUCONEST® in Improving Neurologic Symptoms in Post COVID-19 Infections

• Many patients who have been diagnosed with COVID find themselves experiencing neurological symptoms post COVID infection.
• Symptoms of post COVID neurological symptoms include extreme fatigue, loss of taste and/or smell, brain fog, seizures, tremor, and in some instances strokeStudy Benefits
• The purpose of the study is to determine if treating subjects with post COVID neurological symptoms with RUCONEST® will improve their neurological symptoms
• The use of RUCONEST® is being tested to see if the drug can assist in correcting the immune dysfunction that results from a deficit in the immune response due to COVID infection

Study Volunteers Must Meet the Following Criteria

• Males and females ages 18-75
• Previous COVID diagnosis
• Development of neurological symptoms post COVID

Study Participant Expectations

• Neurological assessments and questionnaires will be completed at each visit
• Blood samples will be collected throughout the study
• Subject will be compensated for time and travel
• Each RUCONEST® infusion could last up to 2 hours
• Each subject will receive 8 RUCONEST® infusions during study treatment period
• Each subject will receive a total of 16 infusions
• Total length of study participation is 19 weeks

Cost

• There is no cost to participate. Patients who qualify may be compensated for time and travel.

You can contribute to medical research that may lead to new treatment options.

• You can play a more active role in your own health care.
• You can obtain medical care during the trial.

A “Clinical Trial” is a research study designed to answer specific questions about investigational treatments or new ways of using known treatments.

• Physicians conduct clinical trials according to strict rules set by the Food and Drug Administration (FDA) and ethic review.